Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 1, 2014, Pages 113-117

  Hawro, T ^a   Saluja, R ^a   Weller, K ^a   Altrichter, S ^a   Metz, M ^a   Maurer, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

atopic dermatitis; dorsal root ganglia; interleukin 31; pruritus; vascular endothelial growth factor

Indexed keywords

HISTAMINE; INTERLEUKIN 31; SODIUM CHLORIDE;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ERYTHEMA; FEMALE; HUMAN; IN VIVO STUDY; MALE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; SKIN PRURITUS; SKIN TEST;

ATOPIC DERMATITIS; DORSAL ROOT GANGLIA; INTERLEUKIN-31; PRURITUS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ADULT; CASE-CONTROL STUDIES; DERMATITIS, ATOPIC; ERYTHEMA; FEMALE; HUMANS; INTERLEUKINS; MALE; PRURITUS; SKIN TESTS; TIME FACTORS;

EID: 84892727105     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12316     Document Type: Article

References (21)

1. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5: 752-760.
2. Zhang Q, Putheti P, Zhou Q, Liu Q, Gao W,. Structures and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev 2008; 19: 347-356.
3. Kasraie S, Niebuhr M, Baumert K, Werfel T,. Functional effects of interleukin 31 in human primary keratinocytes. Allergy 2011; 66: 845-852.
4. Cornelissen C, Marquardt Y, Czaja K, Wenzel J, Frank J, Luscher-Firzlaff J, et al. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. J Allergy Clin Immunol 2012; 129: 426-433.
5. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006; 117: 411-417.
6. Bando T, Morikawa Y, Komori T, Senba E,. Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression patterns. Neuroscience 2006; 142: 1263-1271.
7. Gonzales AJ, Humphrey WR, Messamore JE, Fleck TJ, Fici GJ, Shelly JA, et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol 2013; 24: 48-53.
8. Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M, Yao L, et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006; 117: 418-425.
9. Neis MM, Peters B, Dreuw A, Wenzel J, Bieber T, Mauch C, et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 2006; 118: 930-937.
10. Nobbe S, Dziunycz P, Muhleisen B, Bilsborough J, Dillon SR, French LE, et al. IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis. Acta Derm Venereol 2012; 92: 24-28.
11. Raap U, Wichmann K, Bruder M, Stander S, Wedi B, Kapp A, et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 2008; 122: 421-423.
12. Raap U, Weissmantel S, Gehring M, Eisenberg AM, Kapp A, Folster-Holst R,. IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr Allergy Immunol 2012; 23: 285-288.
13. Church MK,. Investigating bradykinin-induced reactions in the skin through microdialysis. Clin Exp Allergy 1997; 27 (Suppl 2): 28-32.
14. Steinhoff M, Bienenstock J, Schmelz M, Maurer M, Wei E, Biro T,. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 2006; 126: 1705-1718.
15. Ip WK, Wong CK, Li ML, Li PW, Cheung PF, Lam CW,. Interleukin-31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen-activated protein kinase signalling pathways: implications for the allergic response. Immunology 2007; 122: 532-541.
16. Krause K, Krull C, Kessler B, Lange-Asschenfeldt B, Maurer M, Metz M,. Effective control of recalcitrant pruritus by bevacizumab: a possible role for vascular endothelial growth factor in chronic itch? Acta Derm Venereol 2013; 93: 175-179.
17. Hood JD, Meininger CJ, Ziche M, Granger HJ,. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998; 274 (Pt 2): H1054-H1058.
18. Thijs AM, van Herpen HC, Sweep FC, Geurts-Moespot A, Smits P, van der Graaf WT, et al. Role of endogenous vascular endothelial growth factor in endothelium-dependent vasodilation in humans. Hypertension 2013; 61: 1060-1065.
19. Wahlgren CF, Tengvall Linder M, Hagermark O, Scheynius A,. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res 1995; 287: 572-580.
20. Wahlgren CF, Hagermark O, Bergstrom R,. Patients' perception of itch induced by histamine, compound 48/80 and wool fibres in atopic dermatitis. Acta Derm Venereol 1991; 71: 488-494.
21. Giannetti A, Girolomoni G,. Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 1989; 121: 681-688.